Monday, February 17, 2020

Digital Blood Pressure Monitors Market to Gain from Rising Demand for Early Diagnosis of Diseases

The global digital blood pressure monitors market is projected to achieve a market figure of USD 1440.3 million by 2025, growing at a CAGR of 10.1%. Rising prevalence of hypertension and associated disorders is cited be one of the main factors driving the global digital blood pressure monitors growth. Hypertension, also known as elevated blood pressure, is a severe physiological condition that can lead to serious disorders in the kidneys, heart, and brain such as stroke and blindness. For example, of the 17 million annual global deaths, 55% were caused by cardiovascular diseases, resulting from raised blood pressure, as stated by the World Heart Federation. 

Get Sample PDF Brochure

According to the World Health Organization (WHO), around 40% of the world’s population is suffering from hypertension, impacting economies and public health negatively. This augurs well for the global digital blood pressure monitors market growth as elevated BP levels will raise the demand for digital BP monitoring devices.
Some of the key participants in the global digital blood pressure monitors market include:
  • Masimo Corporation
  • Welch Allyn
  • Smiths Group
  • GE Healthcare
  • Omron Healthcare
  • American Diagnostic Corporation
  • Nihon Kohden Corporation
According to the Fortune Business Insights report, titled “Digital Blood Pressure Monitors Market Size, Share and Industry Analysis By Product Type (Arm Type & Wrist Type), End User (Hospitals, Ambulatory Surgical Centers & Clinics, Homecare Settings & Others) and Regional Forecast, 2018 – 2025”, the global digital blood pressure monitors market value in 2017 was USD 666.6 million. The report also contains a comprehensive analysis of all the possible factors and trends that will shape the market during the forecast period. 

"Inherent Disadvantages of Mercury Sphygmomanometers to Boost Market Expansion"

Mercury sphygmomanometers are plagued by multiple disadvantages, forcing patients and doctors to shift towards digital blood pressure monitors. For example, since mercury is toxic for human and ecological health, any spills can be hazardous and the recovery costs. Furthermore, reading mercury sphygmomanometers requires great skill, which everyone may not possess. Additionally, these devices can experience a lag if they are not properly vented, leading to inaccurate readings. 

Lastly, maintaining mercury sphygmomanometers is a tedious task and their accuracy is heavily dependent on how one is holding them. These limitations are expected to boost the adoption rate of digital BP monitors and expand the global digital blood pressure monitors market size.

"High-stress Levels in the US to Propel the Market in North America"

According to a survey conducted by Gallup, 55% of Americans suffer from persistent stress. More importantly, the most stressed is experienced by younger Americans aged between 15 and 49, that is, majority of their working population. As a result, North America is anticipated to hold the major portion of the global digital blood pressure monitors market during the forecast period. 

Rising hypertension incidence rate and widespread prevalence of cardiovascular diseases are expected to drive the market for digital blood pressure monitors in Europe till 2025. In Asia-Pacific, expanding working population in India and China is the main factor that will significantly accelerate the global digital blood pressure monitors market revenue in the foreseeable future.

"Exciting Innovations to Intensify Market Competition"

Lack of physical activity, high cost of healthcare, and increasing levels of workplace-related stress has led to a speedy rise in the demand for digital blood pressure monitors. This has opened new vistas for players in the global digital blood pressure monitors market to explore and exploit. 

Read more in this press release:
https://www.fortunebusinessinsights.com/press-release/blood-pressure-monitor-market-9106

One of the dominant strategies being adopted to gain an edge in the market is the creation of novel products. For example, Panasonic developed the EW3109W Upper Arm Blood Pressure Monitor that immediately alerts the user if she is experiencing hypertension. It also allows for storing of 90 readings and comes with an in-built LCD screen for ease of reading.  Similarly, iHealth has come out with its iHealth Feel Wireless Blood Pressure Monitor that can take 80 readings in a single charge. It is connected to the user’s Android or iOS device.

Get more details here:
https://www.fortunebusinessinsights.com/industry-reports/blood-pressure-monitors-market-100059

Friday, February 14, 2020

Medical Devices Market to Reach US$ 602.1 Billion by 2025, Continuous Product Innovations to Support Growth

Companies operating in the Global Medical Device Market are likely to leverage product innovations to establish a strong foothold.  Manufacturers are likely to continue focusing on modifying medical devices to gain competitive strength. The presence of several players at global as well as regional levels, has rendered the global medical devices market highly fragmented. Some of the major players operating in the global medical devices market are De Puy Synthes, Philips Healthcare, Ethicon LLC., Cardinal Health, Medtronic, Baxter International Inc. and Siemens Healthineers.
Get Sample PDF Brochure

Among these, Medtronic held the highest share in the global medical devices market in the year 2017. The company is likely to show positive growth in the coming years owing to its diverse product portfolio and innovative strategies. In addition to this, the company has a strong and established brand presence. This, coupled with the robust R&D focus, will enable the company to maintain a stronghold in the global medical devices market. Fortune Business Insights in a new study attributes such factors to catapult Medtronic to the fore of the global medical devices market.
The study is titled Medical Devices Market: Global Market Analysis, Insights and Forecast, 2018-2025,” and is currently available for sale on the official website. The report forecasts the global medical devices market to exhibit a CAGR of 5.3% between 2018 and 2025. At this pace, it is expected to reach US$ 602.1 Bn by the end of 2025, as against US$ 397.5 Bn valued in 2017.
“Strategic initiatives by several market players will help them to contribute towards the growth of the medical devices market,” says a lead analyst at FBI. Some of the recent innovations by leading players, which are likely to boost the medical devices market are:
  • In 2017, DePuy Synthes launched Purevue, a high definition visualization system to capture HD images. The system is also used to perform minimally invasive endoscopic surgeries.
  • In 2018, Siemens Healthineers launched a next-generation ultrasound system called Acuson Juniper to use it across different clinical segments.
Rising Geriatric Population to Increase Adoption of Medical Devices
Fortune Business Insights projects the demand for medical devices to increase in the coming years owing to the rise in geriatric population. As per the National Institute of Health (NIH), the U.S. listed around 617 million people aged 65 years and above in 2015. The figure is forecast to rise further in the coming years, thus enabling growth in the medical devices market. Several other factors spelling growth for the medical devices industry are:
  • Rising prevalence of chronic diseases such as cancer, coupled with growth in surgical procedures across the world, boosts the market.
  • Governments across regions are investing in the new generation medical devices, thus creating a growth space for the medical devices market.
  • Technological advancements and rising demand for innovative therapies to overcome unmet needs in the healthcare sector are supporting growth of the medical device market. This has further led to the  advent ofnew medical device designs, which will drive the medical devices market during the forecast period.
In terms of end user, the hospitals & ambulatory surgical centers segment dominated the global medical devices market in 2017. Developing healthcare infrastructure, rising healthcare expenditures, increasing emphasis on better patient outcomes, and lucrative reimbursement policies are expected to drive the hospitals & ambulatory surgical centers segment during the forecast period.  Fortune Business Insights expects the demand from hospitals to shoot up during the forecast period.
Rapid Adoption of Novel Medical Technologies Boosts Medical Devices Market in Asia Pacific
The global medical devices market in North America was valued at US$159.0 Bn in the year 2017. The region is likely to hold a considerable share in the global medical devices market during the forecast period. This is ascribed to the high adoption rate of advanced treatments and large target patient population. Besides North America, Asia Pacific is forecast to offer lucrative growth opportunities to the medical devices market. The region exhibits high growth potential owing to rising disposable income among consumers and improving healthcare infrastructure.
However, the medical devices market in Europe is anticipated to expand at a relatively lower growth rate during 2018-2025, attributed to a relatively mature market and the smaller patient pool.

Wednesday, February 12, 2020

Magnetic Resonance Imaging (MRI) Systems Market Is Predicted to Grow Driven by Increasing R&D Activities in the Field of Neuroscience

Rapidly increasing healthcare expenditure in emerging nations is propelling the growth of the magnetic resonance imaging systems market “Magnetic Resonance Imaging (MRI) Systems Market Size, Share and Global Trend by Strength (Less than 1.5 T, 1.5 T & More than 1.5 T), Application (Musculoskeletal, Neurology, Cardiology, Body Imaging), End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers) and Geography Forecast till 2025.” The global magnetic resonance imaging system market is expected to reach a value of US$ 11,725.9 Mn by 2025 from US$ 7,165.6 Mn in 2017 at an exceptional CAGR of 6.4%.

Get Sample PDF Brochure

"Extensive R&D Activities to Facilitate Growth"

Expeditiously increasing healthcare reimbursement policies along with promptly developing healthcare infrastructure in developing as well as developed nations are encouraging the use of the magnetic resonance imaging machines. Recent technological advancements in magnetic resonance imaging procedures and extensive research and development in the field of neuroscience are leading to the adoption of magnetic resonance imaging machines which is then boosting the magnetic resonance imaging systems market. 

Further rising prominence in leveraging diagnostic imaging has led to the development of advanced MRI uses such as neonatal MRI, breast MRI, and others. In addition, the efficient image acquisition of MRI machines along with high spatial resolution are some of the features which are steering the growth and fueling demand for MRI scan.

"1.5T to Be the Most Preferred MRI Option"

The market on the basis of strength are segmented into less than 1.5 T, 1.5 T and more than 1.5 T. Of these, 1.5 T accounted for 70.5% of the MRI systems market share in 2017 and is predicted to grow at a high CAGR attributing to the integration of innovative algorithms in MRI machines along with reasonable costs. MRI systems on the basis of application are segmented into musculoskeletal, neurology, cardiology, body imaging. 

Musculoskeletal segment is predicted to grow at a remarkable rate in the forthcoming year owing to the established clinical efficiency of MRI machines in comprehensive bone imaging. Furthermore, neurology is also predicted to grow at a comparatively higher rate due to development in neuroscience, most conspicuously in emerging countries. Magnetic resonance imaging systems market on the basis of end-user is segmented into ambulatory surgical centers, hospitals, and diagnostic centers. 

The hospital sector in developing nations is expected to witness high growth in the forthcoming year owing to the allocation of significant funds by the government. However, the cost of MRI machines is proportionately related to the technology embedded in it. Handling costs of acquisition and maintenance of MRI machines with advanced technology for improved results is a major obstacle for the growth machine resonance imaging procedures. Therefore, this factor is restricting the growth of the global magnetic resonance imaging system market

"Rising Prevalence of Neurological Disorders in Asia Pacific to Promote Growth"

Geographically, the global magnetic resonance imaging systems market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa. The Asia Pacific market was valued at US$ 3,159.5 Mn in 2017 and is predicted to lead the global MRI systems market in the forthcoming year. The increasing acceptance of MRI machines for diagnostic imaging and execution of strategies by market players is fostering the growth in the region. 

Read more in this press release:

Increasing incidences of neurological disorder and musculoskeletal is further boosting the magnetic resonance imaging systems market. Extensive R&D activities for cardiovascular and neurology are likely to contribute significantly to the growth of the magnetic resonance imaging systems market in Europe and North America.

Global magnetic resonance imaging systems market key players are GE Healthcare, Siemens Healthcare, Koninklijke Philips N.V., Canon Inc., Hitachi, Ltd., Esaote SpA, Shenzhen Anke High-tech Co., Ltd., Time Medical Holding, SHENZHEN BASDA MEDICAL APPARATUS CO., LTD., Fonar Corporation, and other prominent players


Get more details here:
https://www.fortunebusinessinsights.com/industry-reports/magnetic-resonance-imaging-mri-systems-market-100087

Global Dental Implants Market to Gain Traction; Dentsply Launches Lucitone HIPA Denture Base: Fortune Business Insights

The global dental implants market size is set to reach USD 5,725.7 million by 2026, exhibiting a CAGR of 5.1% during the forecast period. Increasing aging population is one of the key factors driving growth of this market. Aging entails a host of health issues and oral health is one of the most prominent among them. Weakening of muscles, improper bowel movement, and slow metabolism are some of the primary causes of oral diseases during old-age.

Get Sample PDF Brochure


The World Health Organization (WHO) states that the rate of aging of populations around the world is faster than it was in the past. According to it, as early as 2020, the world will witness the number of people aged above 60 will outnumber children below the age of 5. The organization predicts that by 2050, close to 22% of the world’s population will be above the age of 60. This will likely fuel the demand for dental implants as oral care becomes a priority among old people.

According to the Fortune Business Insights report, titled “Dental Implants Market Size, Share and Industry Analysis By Material (Titanium Implants, Zirconium Implants), By Type (Endosteal Implants, Subperiosteal Implants, Transosteal Implants), By Design (Tapered Implants, Parallel Implants), By End-user (Hospitals, Dental Clinics, Academic & Research Institutes) and Regional Forecast, 2019 – 2026”, the market value stood at USD 3,870.0 million in 2018.

The report also provides a comprehensive overview of the industry outlook and future prospects, along with an exhaustive analysis of the trends, factors, and the regional and competitive landscape that will chart the growth-path for the market during the forecast period.

"Rising Prevalence of Diabetes to Favour Market Expansion"

Diabetic people, especially those whose diabetes in out of control, are known to suffer from dental problems. Gum infections are common among this populace as diabetes decreases blood supply to the gums. Dry-mouth, a common effect of high blood sugar, can make gum diseases worse and low saliva levels in the mouth can lead to plaque build-up. This can cause tooth decay and create a need for dental implants. Moreover, the prevalence of diabetes is increasing globally. For example, according to the International Diabetes Federation (IDF), by 2045, the number of adults between the ages of 20 and 79 suffering from diabetes will rise to 629 million, with majority of them living in low and middle income countries.

As a result, the demand for dental implants is highly likely to skyrocket in the coming decade. As per the dental implants market trends, titanium implants will experience a demand surge owing to their easy application in most dental procedures and non-allergic nature. This segment will be augmented by the growing adoption of computer-aided design / computer-aided manufacturing (CAD/CAM) technology.

"Presence of Key Companies to Accelerate Growth in Europe; North America to Follow Closely"

Among regions, Europe is expected to dominate the dental implants market share on account of a swiftly swelling geriatric population, coupled with presence of important market players and high adoption of new dental technologies. North America is anticipated to display an impressive CAGR due to increasing aging population. In Asia-Pacific, increasing disposable income will ramp up the adoption rate, in spite of high dental implants cost. Furthermore, a thriving medical tourism industry will further catalyse the market in the region.

"Straumann AG Partners With Modern Dental to Establish Presence in Hong Kong and Macau"

In September 2019, Basel-based Institut Straumann joined hands with Hong Kong-based Modern Dental Group Limited to cater to the dental needs of Hong Kong and Macau. This joint venture will be fructified through the creation of a distribution company called Peak Dental Solutions Hong Kong Ltd. Such strategic collaborations will enable major companies in this market to establish their presence globally and build a strong distribution network in other regions.

Read more details in this press release:
https://www.fortunebusinessinsights.com/press-release/dental-implants-market-9116

Some companies are also acquiring other competitors to gain an extra edge in the market. For instance, Dentsply Sirona acquired Israel-based MIS Implants Technologies, a fellow competitor in this market.
Fortune Business Insights identifies some of the key players in the dental implants market:
  • Zimmer Biomet
  • Anthogyr Group
  • Danaher
  • BioHorizons
  • Institut Straumann AG
  • Henry Schein, Inc.
  • Osstem Implant
  • Dentsply Sirona
  • CeraRoot SL

 Get more details here:
https://www.fortunebusinessinsights.com/industry-reports/dental-implants-market-100443

Tuesday, February 11, 2020

Rheumatoid Arthritis Therapeutics Market to Rise at A Rate of 4.6 %; Improvements In Diagnostics And Healthcare Infrastructure Will Contribute Growth, says Fortune Business Insights





Pune, India, 17th June 2019: Rising awareness about arthritis and its prevention is propelling the growth of rheumatoid arthritis therapeutics Market says, Fortune Business Insights in a published report titled “Rheumatoid Arthritis Therapeutics Market Size, Share and Global Trend By Product Type (Biologics, Non-Biologics), Distribution Channels (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) & Geography Forecast till 2025.”As per the report the market is projected to reach at Us$ 33,958.4 Mn by 2025 from US$ 23,822.5 Mn in 2017 at a remarkable  4.6% CAGR.
Get Sample PDF Brochure


"Reimbursement Policies and Demand for Effective Drugs Despite their High Cost Are Supporting Market Growth"

Recent developments in diagnostics and healthcare centers in emerging nations are predicted to exhibit higher diagnosed cases. Furthermore, the rising incidence of rheumatoid arthritis is likely to fuel demand for rheumatoid arthritis therapeutics during the forecast period. The rising geriatric population and growing awareness about arthritis and its preclusion among patients are predicted to boost the global rheumatoid arthritis therapeutics market during the forecast period.

The existence of high-cost drugs and reimbursement policies are some of the key factors favoring the growth of rheumatoid arthritis therapeutics market. For instance, Disease-Modifying Antirheumatic Drug (DMARD) mostly used for treating rheumatoid arthritis are now also being used for treating conditions such as, psoriatic arthritis, systemic lupus erythematosus and ankylosing spondylitis.

"FDA’s Approval of Enbrel(R) to Foster Increased Growth"

Food and Drug Administration permitted the use for Enbrel, as a treatment for improving physical function in patients with minutely or severely active rheumatoid arthritis. The approval of Enrabel is expected to generate demand among rheumatoid arthritis patients, owing to the claim of improved physical function by the drug. This factor is predicted to have a major contribution to the growth of the global market. Key players such as AbbVie Inc, Amgen Inc., UCB SA and others. Among which AbbVie Inc was appeared to be leading in 2017 owing to Humira, a medication used mainly for treating rheumatoid arthritis. 

This drug is predicted to witness high demand for the treatment of rheumatoid arthritis. Furthermore, the rising prevalence and growing awareness about breathing disorders is also resulting in high demand for rheumatoid arthritis therapeutics and enabling the growth of the global rheumatoid arthritis therapeutics

"North America to Emerge Dominant by 2025"

Geographically, the global rheumatoid arthritis therapeutics market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America dominated the global rheumatoid arthritis therapeutics market in 2017 and was valued at US$ 9,929.6 Mn and is anticipating to dominate and account for maximum share in the global market during the forecast period. The increasing prevalence of rheumatoid arthritis is driving the growth of the rheumatoid arthritis therapeutics market in the region. 

Rising awareness about disorders and elevation in healthcare spending is another factor favoring the growth of the market. In addition, growing penetration of rheumatoid arthritis treatment drugs by key companies such as biologics is fueling the demand for advanced treatment in patients. 

Read more in this press release:

The rising number of healthcare infrastructure in emerging nations such as India, China, Japan, is also one of the key factors which are expected to progressively influence the consumption of rheumatoid arthritis treatment medications. Therefore, the aforementioned factors are resulting in the high growth rate of rheumatoid arthritis therapeutics market in the region.

Some of the key market players are Pfizer Inc., Amgen Inc., Johnson & Johnson Services, Inc., CELGENE CORPORATION, Bristol-Myers Squibb Company, Hoffmann-La Roche AG, UCB S.A., Eli Lilly and Company, Gilead Sciences, Inc. Other players

Get more details here:

Thursday, February 6, 2020

Diabetes Monitoring Devices Market to Expand at 5.4% CAGR by 2026, F. Hoffmann-La Roche’s Robust Distribution Network Strengthens its Market Position


The global diabetes monitoring devices market is expected to rise owing to increasing awareness about the self-management of diabetes. Fortune Business Insights in a report, titled “Diabetes Monitoring Devices: Global Market Analysis, Insights and Forecast, 2019-2026” offers valuable insights into the market, highlighting opportunities and threats alike. 

Get Sample PDF Brochure

The global market is expected to yield huge profits facilitated by remarkable developments in diabetes management. Moreover, diabetes monitoring devices help to monitor several health conditions which include neuropathy, cardiovascular diseases, and diabetic retinopathy. As per International Diabetes Foundation (IDF), the number of people suffering from diabetes was 415 million in 2015 and is expected to reach 642 million by the year 2040. The rising prevalence of diabetes across the globe is a major factor driving the market.


In 2017, the global market for diabetes monitoring devices was valued at US$ 21614.7 and is anticipated to reach US$ 32881.9 Mn by 2026. The global market is expected to rise at a CAGR of 5.4% during the forecast period.

"Asia Pacific Registers Considerable Growth with Rising Number of Diabetic Patients"

Among regions, North America is anticipated to lead the global diabetes monitoring devices market during the forecast period. In the year 2018, the regional market was worth US$ 7092.0 Mn. This is primarily on account of high adoption of advanced diabetes monitoring devices in the U.S. Recent innovations in technology and increasing healthcare expenditure are registering growth opportunities in the market in this region.

The market in Asia Pacific is expected to rise at a higher CAGR over the forecast years. Innovations in diabetes management and increasing patient pool for diabetes are factors driving the market in this region. Increased Healthcare spending by governments is expected to stimulate growth in the market. This is primarily done to improve healthcare services and develop cost-effective diabetes diagnostic devices in Asia Pacific.    

"Diabetes Monitoring Devices offer Real-time Information on Blood Sugar Levels, A Key Factor Augmenting Demand"

The rising aging population across the world is boosting the diabetes monitoring devices market. Furthermore, technological developments in diabetes diagnostic devices is act as a potential growth enabler in the market. A lead analyst at Fortune Business Insights said, “the convenience of using advanced diabetes monitoring devices over conventional devices is expected to help geriatrics keep a track of their blood sugar levels in real-time.” Rising concerns and increasing patient awareness about the blood sugar level are likely to fuel demand for self-monitoring diabetes monitoring devices. 

Several people are installing diabetes monitoring apps to keep a track of their blood glucose level. The app sends notification on medication doses, carb intake and other important information. High stress levels and alcohol consumption are potential growth triggers in the market. This, coupled with rapid adoption to sedentary lifestyle, contributes to the growth of the market. These factors are expected to increase the adoption of diabetes monitoring system between 2018 and 2026.

Rising preference for minimally-invasive surgeries is encouraging companies to develop diabetes monitoring devices without needles. This in turn, will help the market grow at an accelerated rate in the coming years.

"Availability of Alternatives to Hinder the Growth of the Market by 2026"

Especially in rural areas, lack of awareness about the diabetes management is hampering the growth of the diabetes monitoring devices market. Also, increasing number of insulin pumps, supplements, drugs, and other alternatives are likely to pose a serious threat to the market. People prefer to use alternatives owing to the mounting cost associated with diabetic monitoring devices. Nonetheless, technological advancements are expected to push growth in the market by introducing cost-0effective diabetes monitoring solutions.

Read More in this Press Release:

"Medtronic Joined Hands with Fitbit to Promote the Importance of Physical Activity"

Some of the leading market players in the global diabetes monitoring devices market are focusing on strategic partnerships to offers a strong product portfolio and strengthen their position. These leading players include Lifespan Inc., F. Hoffmann-La Roche Ltd., Ascensia Diabetes Care Holdings AG., Medtronic, Terumo Medical Corporation, DiaMonTech GmbH, Sanofi, and Abbott. Among these, Medtronic, F. Hoffmann-La Roche Ltd., and Abbott dominated the global diabetes monitoring devices market in the year 2018.

Further to this, F. Hoffmann-La Roche Ltd. leads the global market owing to its strong distribution network and wide availability of blood glucose meters. Companies are planning to focus on introducing advanced glucose meters to stay industry specific. For instance, Lifespan Inc. made an agreement with Sanvita Medical, LLC in May 2019. The agreement was done to market continuous glucose monitoring sensors or CGM sensors.

Get More Details Here:

Monday, January 27, 2020

Global Intravenous Immunoglobulins Market to Reach US$ 15,789.1 Mn by 2025 Gaining from High Adoption of Immunoglobulin in Hospitals


The global prevalence of primary immunodeficiency is rising, giving impetus to the global intravenous immunoglobulins market. A report is published by Fortune Business Insights, titled “Intravenous Immunoglobulins: Global Market Analysis, Insights and Forecast, 2018-2025,” offers in-depth insights into the market. As per the report, in 2017 the global market was worth US$ 9,787.6 Mn. The market is anticipated to further expand at a CAGR of 6.2% and reach US$ 15,789.1 by the end of 2025.
Get Sample PDF Brochure


In terms of indication, the report classifies the global market in primary immunodeficiency, chronic inflammatory demyelinating polyneuropathy (CIDP), and others. Primary immunodeficiency was leading the market in 2017. The segment accounted for 28.6% of the global market in 2017. During the forecast period 2018-2025, the segment is likely to witness expansion at an impressive pace. Diagnosis of primary immunodeficiency is gaining momentum and encouraging the adoption of intravenous immunoglobulins. Moreover, e patients who are incapable to perform self-intervention of  immunoglobulin are further generating high demand in the intravenous immunoglobulins market. Besides this, the chronic inflammatory demyelinating polyneuropathy segment is forecast to show a slower growth owing to the low prevalence of the disease the segment may witness slow growth.

"Intravenous Immunoglobulin Application in Hospitals to Rise Persistently"

Intravenous immunoglobulin is the most common route of administration of immunoglobulins, which is the chief driver of the global market. The rising demand from hospitals and specialty clinics is anticipated to encourage the adoption of intravenous immunoglobulins. Furthermore, key companies are increasingly investing in research and development of advanced intravenous immunoglobulins. Such researches are likely to enable growth in the market over the forecast period.

Immunoglobulins are proven to be one of the best treatment options for various immune diseases. Owing to the high popularity of immunoglobulins, the market is foreseen to witness high demand.

On the contrary, factors that may restrain the global intravenous immunoglobulins market are side effects associated with Intravenous immunoglobulins and intravenous immunoglobulin’s high cost.

"North America to Continue Dominating Global Market"

The North America intravenous immunoglobulins market was worth US$ 5,587.4 Mn in 2017. The region is further expected to emerge dominant over the forecast period. The increasing number of patients in the region is anticipated to drive the regional market. Moreover, in terms of dominance of route of administration, intravenous (IV) is the most dominating type in developing nations. This is likely to enable growth in market. Besides this, the advanced intravenous immunoglobulins are rapidly adopted in developed nations. This in response if fueling the demand in market. Asia Pacific is anticipated to expand at a promising CAGR. Owing to the high prevalence of primary immunodeficiency in Asian population, the market is foreseen to witness demand for immunoglobulin.

Read More in this Press Release:

The competition among the key players is increasing. Owing to the prevailing opportunities, players are focusing on the adoption of innovative strategies to gain a strong brand presence. In 2017 Grifols, S.A. was leading the global market owing to its diverse product portfolio. The Grifols, S.A. also holds a major share in the European and North America intravenous immunoglobulins market. Other key companies operating in the global intravenous immunoglobulins market are CSL Behring, Grifols, S.A., Kedrion S.p.A, Octapharma, Bio Products Laboratory Ltd., Biotest AG, China Biologic Products Holdings, Inc., LFB SA, and Shanghai RAAS Blood Products Co., Ltd.


Get More Details Here: